{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:03:26Z","timestamp":1792440206196,"version":"4.5.0"},"reference-count":96,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010663","name":"H2020 European Research Council","doi-asserted-by":"publisher","award":["945473"],"award-info":[{"award-number":["945473"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002108","name":"Friedreich's Ataxia Research Alliance","doi-asserted-by":"publisher","award":["2024.04513"],"award-info":[{"award-number":["2024.04513"]}],"id":[{"id":"10.13039\/100002108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002108","name":"Friedreich's Ataxia Research Alliance","doi-asserted-by":"publisher","award":["SFRH\/BD\/09513\/2020"],"award-info":[{"award-number":["SFRH\/BD\/09513\/2020"]}],"id":[{"id":"10.13039\/100002108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002108","name":"Friedreich's Ataxia Research Alliance","doi-asserted-by":"publisher","award":["SFRH\/BD\/90730\/2012"],"award-info":[{"award-number":["SFRH\/BD\/90730\/2012"]}],"id":[{"id":"10.13039\/100002108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002108","name":"Friedreich's Ataxia Research Alliance","doi-asserted-by":"publisher","award":["2021.05776"],"award-info":[{"award-number":["2021.05776"]}],"id":[{"id":"10.13039\/100002108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018703","name":"European Innovation Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018703","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030861","name":"COMPETE 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030861","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011929","name":"Programa Operacional Tem\u00e1tico Factores de Competitividade","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011929","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006190","name":"Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013322","name":"European Federation of Pharmaceutical Industries and Associations","doi-asserted-by":"publisher","award":["101145599"],"award-info":[{"award-number":["101145599"]}],"id":[{"id":"10.13039\/100013322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018357","name":"American Portuguese Biomedical Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018357","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["POCI-01-0145-FEDER029716"],"award-info":[{"award-number":["POCI-01-0145-FEDER029716"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDP\/04539\/2025"],"award-info":[{"award-number":["UIDP\/04539\/2025"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["2022.06118"],"award-info":[{"award-number":["2022.06118"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["JPND\/0001\/2022"],"award-info":[{"award-number":["JPND\/0001\/2022"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["LA\/P\/0058\/2020"],"award-info":[{"award-number":["LA\/P\/0058\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDB\/04539\/2025"],"award-info":[{"award-number":["UIDB\/04539\/2025"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["CENTRO-01-0145-FEDER-022095"],"award-info":[{"award-number":["CENTRO-01-0145-FEDER-022095"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ymthe.2025.10.022","type":"journal-article","created":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T22:30:04Z","timestamp":1760221804000},"page":"161-178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Extracellular vesicles-associated AAVs for the treatment of Machado-Joseph disease"],"prefix":"10.1016","volume":"34","author":[{"given":"Carina","family":"Henriques","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patr\u00edcia","family":"Albuquerque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Rufino-Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel M.","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Leandro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catarina O.","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme","family":"Lopes-Gabriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"de Sousa-Louren\u00e7o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara M.","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laetitia S.","family":"Gaspar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana D.","family":"Lobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Carolina","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa M.","family":"Ribeiro-Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrique","family":"Gir\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9lia M.","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Baganha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f3nia","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casey A.","family":"Maguire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magda M.","family":"Santana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5831-3307","authenticated-orcid":false,"given":"Lu\u00eds","family":"Pereira de Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui Jorge","family":"Nobre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2025.10.022_bib1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/mds.870070302","article-title":"Machado-Joseph disease: An autosomal dominant motor system degeneration","volume":"7","author":"Rosenberg","year":"1992","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ymthe.2025.10.022_bib2","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/ng0793-300","article-title":"The gene for Machado-Joseph disease maps to human chromosome 14q","volume":"4","author":"Takiyama","year":"1993","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2025.10.022_bib3","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ng1194-221","article-title":"CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1","volume":"8","author":"Kawaguchi","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2025.10.022_bib4","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.pneurobio.2011.11.006","article-title":"Toward understanding Machado-Joseph Disease","volume":"97","author":"Costa","year":"2012","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ymthe.2025.10.022_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmed.2025.06.007","article-title":"Spinocerebellar ataxia type 3: from pathogenesis to promising therapeutics","author":"Silva","year":"2025","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ymthe.2025.10.022_bib6","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1093\/brain\/awae012","article-title":"Viral-based animal models in polyglutamine disorders","volume":"147","author":"Henriques","year":"2024","journal-title":"Brain"},{"key":"10.1016\/j.ymthe.2025.10.022_bib7","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S1474-4422(04)00737-9","article-title":"Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis","volume":"3","author":"Sch\u00f6ls","year":"2004","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ymthe.2025.10.022_bib8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1750-1172-6-35","article-title":"Machado-Joseph disease: From first descriptions to new perspectives","volume":"6","author":"Bettencourt","year":"2011","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymthe.2025.10.022_bib9","series-title":"GeneReviews\u00ae","article-title":"Spinocerebellar Ataxia Type 3","author":"Paulson","year":"1993"},{"key":"10.1016\/j.ymthe.2025.10.022_bib10","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41572-019-0074-3","article-title":"Spinocerebellar ataxia","volume":"5","author":"Klockgether","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ymthe.2025.10.022_bib11","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1093\/hmg\/ddq111","article-title":"Silencing ataxin-3 mitigates degeneration in a rat model of Machado-Joseph disease: No role for wild-type ataxin-3?","volume":"19","author":"Alves","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2025.10.022_bib12","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1093\/brain\/awr047","article-title":"Overexpression of the autophagic beclin-1 protein clears mutant ataxin-3 and alleviates Machado-Joseph disease","volume":"134","author":"Nascimento-Ferreira","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.ymthe.2025.10.022_bib13","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1093\/brain\/awt144","article-title":"Beclin 1 mitigates motor and neuropathological deficits in genetic mouse models of Machado-Joseph disease","volume":"136","author":"Nascimento-Ferreira","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.ymthe.2025.10.022_bib14","doi-asserted-by":"crossref","first-page":"e100086","DOI":"10.1371\/journal.pone.0100086","article-title":"RNA interference mitigates motor and neuropathological deficits in a cerebellar mouse model of Machado-Joseph disease","volume":"9","author":"N\u00f3brega","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2025.10.022_bib15","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1093\/brain\/awv298","article-title":"Re-establishing ataxin-2 downregulates translation of mutant ataxin-3 and alleviates Machado\u2013Joseph disease","volume":"138","author":"N\u00f3brega","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.ymthe.2025.10.022_bib16","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1089\/hum.2018.157","article-title":"RNA Interference Therapy for Machado-Joseph Disease: Long-Term Safety Profile of Lentiviral Vectors Encoding Short Hairpin RNAs Targeting Mutant Ataxin-3","volume":"30","author":"N\u00f3brega","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2025.10.022_bib17","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.biomaterials.2015.12.021","article-title":"Intravenous administration of brain-targeted stable nucleic acid lipid particles alleviates Machado-Joseph disease neurological phenotype","volume":"82","author":"Concei\u00e7\u00e3o","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.ymthe.2025.10.022_bib18","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.ymthe.2017.01.021","article-title":"Unravelling Endogenous MicroRNA System Dysfunction as a New Pathophysiological Mechanism in Machado-Joseph Disease","volume":"25","author":"Carmona","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.10.022_bib19","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/978-3-319-71779-1_20","article-title":"Gene therapies for polyglutamine diseases","volume":"1049","author":"Matos","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ymthe.2025.10.022_bib20","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.omtm.2019.10.008","article-title":"Development of an AAV-Based MicroRNA Gene Therapy to Treat Machado-Joseph Disease","volume":"15","author":"Martier","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2025.10.022_bib21","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41398-021-01605-2","article-title":"CRISPR\/Cas9 mediated gene correction ameliorates abnormal phenotypes in spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cells","volume":"11","author":"He","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.ymthe.2025.10.022_bib22","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1089\/nat.2021.0020","article-title":"MiRNA-Mediated Knockdown of ATXN3 Alleviates Molecular Disease Hallmarks in a Mouse Model for Spinocerebellar Ataxia Type 3","volume":"32","author":"Nobre","year":"2022","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.ymthe.2025.10.022_bib23","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ymthe.2021.07.012","article-title":"ULK overexpression mitigates motor deficits and neuropathology in mouse models of Machado-Joseph disease","volume":"30","author":"Vasconcelos-Ferreira","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.10.022_bib24","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1093\/brain\/awac473","article-title":"The stress granule protein G3BP1 alleviates spinocerebellar ataxia-associated deficits","volume":"146","author":"Koppenol","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.ymthe.2025.10.022_bib25","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/ana.26713","article-title":"Antisense Oligonucleotide Silencing Reverses Abnormal Neurochemistry in Spinocerebellar Ataxia 3 Mice","volume":"94","author":"McLoughlin","year":"2023","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymthe.2025.10.022_bib26","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.ymthe.2023.04.001","article-title":"Extracellular vesicle-based delivery of silencing sequences for the treatment of Machado-Joseph disease\/Spinocerebellar Ataxia type 3","volume":"31","author":"Rufino-Ramos","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.10.022_bib27","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.molmed.2024.05.004","article-title":"Molecular therapy for polyQ disorders: from bench to clinical trials","volume":"30","author":"de Sousa-Louren\u00e7o","year":"2024","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ymthe.2025.10.022_bib28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/1535676019899502","article-title":"Viral Vector Systems for Gene Therapy: A Comprehensive Literature Review of Progress and Biosafety Challenges","volume":"25","author":"Ghosh","year":"2020","journal-title":"Appl. Biosaf."},{"key":"10.1016\/j.ymthe.2025.10.022_bib29","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1126\/science.149.3685.754","article-title":"Adenovirus-Associated Defective Virus Particles","volume":"149","author":"Atchison","year":"1965","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2025.10.022_bib30","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jconrel.2016.09.011","article-title":"Gene therapy for the CNS using AAVs: The impact of systemic delivery by AAV9","volume":"241","author":"Saraiva","year":"2016","journal-title":"J. Control Release"},{"key":"10.1016\/j.ymthe.2025.10.022_bib31","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1056\/NEJMoa0802315","article-title":"Safety and efficacy of gene transfer for Leber\u2019s congenital amaurosis","volume":"358","author":"Maguire","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2025.10.022_bib32","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/gt.2012.43","article-title":"Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trial","volume":"20","author":"Gaudet","year":"2013","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2025.10.022_bib33","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","article-title":"Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy","volume":"377","author":"Mendell","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2025.10.022_bib34","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1056\/NEJMoa2113708","article-title":"Valoctocogene Roxaparvovec Gene Therapy for Hemophilia A","volume":"386","author":"Ozelo","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2025.10.022_bib35","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ymthe.2021.11.005","article-title":"Long-term efficacy and safety of eladocagene exuparvovec in patients with AADC deficiency","volume":"30","author":"Tai","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.10.022_bib36","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s40265-023-01845-0","article-title":"Etranacogene Dezaparvovec: First Approval Etranacogene Dezaparvovec (Hemgenix \u00ae): Key Points","volume":"83","author":"Heo","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.ymthe.2025.10.022_bib37","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s40265-023-01929-x","article-title":"Delandistrogene Moxeparvovec: First Approval","volume":"83","author":"Hoy","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.ymthe.2025.10.022_bib38","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.omtm.2017.11.007","article-title":"Emerging Issues in AAV-Mediated In Vivo Gene Therapy","volume":"8","author":"Colella","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2025.10.022_bib39","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1089\/hgtb.2012.243","article-title":"Pre-existing Anti\u2013Adeno-Associated Virus Antibodies as a Challenge in AAV Gene Therapy","volume":"24","author":"Louis Jeune","year":"2013","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.ymthe.2025.10.022_bib40","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1089\/hum.2022.138","article-title":"Immune Responses and Immunosuppressive Strategies for Adeno-Associated Virus-Based Gene Therapy for Treatment of Central Nervous System Disorders: Current Knowledge and Approaches","volume":"33","author":"Prasad","year":"2022","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2025.10.022_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119142","article-title":"Challenges in adeno-associated virus-based treatment of central nervous system diseases through systemic injection","volume":"270","author":"Huang","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.ymthe.2025.10.022_bib42","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/mt.2011.303","article-title":"Microvesicle-associated AAV vector as a novel gene delivery system","volume":"20","author":"Maguire","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.10.022_bib43","doi-asserted-by":"crossref","first-page":"7598","DOI":"10.1016\/j.biomaterials.2014.05.032","article-title":"Naturally enveloped AAV vectors for shielding neutralizing antibodies and robust gene delivery invivo","volume":"35","author":"Gy\u00f6rgy","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.ymthe.2025.10.022_bib44","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/gt.2016.11","article-title":"Exosome-associated AAV vector as a robust and convenient neuroscience tool","volume":"23","author":"Hudry","year":"2016","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2025.10.022_bib45","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1182\/bloodadvances.2017010181","article-title":"Enhanced liver gene transfer and evasion of preexisting humoral immunity with exosome-enveloped AAV vectors","volume":"1","author":"Meliani","year":"2017","journal-title":"Blood Adv."},{"key":"10.1016\/j.ymthe.2025.10.022_bib46","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1089\/hum.2021.122","article-title":"Neutralizing Antibody Evasion and Transduction with Purified Extracellular Vesicle-Enveloped Adeno-Associated Virus Vectors","volume":"32","author":"Cheng","year":"2021","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2025.10.022_bib47","doi-asserted-by":"crossref","first-page":"707607","DOI":"10.3389\/fcell.2021.707607","article-title":"AAV-Containing Exosomes as a Novel Vector for Improved Gene Delivery to Lung Cancer Cells","volume":"9","author":"Liu","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ymthe.2025.10.022_bib48","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1089\/hum.2020.328","article-title":"Intravitreal injection of an exosome-associated adeno-associated viral vector enhances retinoschisin 1 gene transduction in the Mouse Retina","volume":"32","author":"Wang","year":"2021","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2025.10.022_bib49","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s11060-018-2889-2","article-title":"Virus vector-mediated genetic modification of brain tumor stromal cells after intravenous delivery","volume":"139","author":"Volak","year":"2018","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.ymthe.2025.10.022_bib50","doi-asserted-by":"crossref","first-page":"e57682","DOI":"10.1371\/journal.pone.0057682","article-title":"Noninvasive and Targeted Gene Delivery into the Brain Using Microbubble-Facilitated Focused Ultrasound","volume":"8","author":"Hsu","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.ymthe.2025.10.022_bib51","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/gt.2014.91","article-title":"Non-invasive, neuron-specific gene therapy can be facilitated by focused ultrasound and recombinant adeno-associated virus","volume":"22","author":"Wang","year":"2015","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2025.10.022_bib52","doi-asserted-by":"crossref","first-page":"989","DOI":"10.3171\/2017.8.JNS17790","article-title":"Safe and stable noninvasive focal gene delivery to the mammalian brain following focused ultrasound","volume":"130","author":"Stavarache","year":"2019","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.ymthe.2025.10.022_bib53","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jconrel.2021.03.029","article-title":"BBB-crossing adeno-associated virus vector: An excellent gene delivery tool for CNS disease treatment","volume":"333","author":"Chen","year":"2021","journal-title":"J. Control Release"},{"key":"10.1016\/j.ymthe.2025.10.022_bib54","article-title":"Isolation of Adeno-associated Viral Vectors Through a Single-step and Semi-automated Heparin Affinity Chromatography Protocol","volume":"206","author":"Lopes","year":"2024","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.ymthe.2025.10.022_bib55","doi-asserted-by":"crossref","first-page":"7034","DOI":"10.1128\/JVI.77.12.7034-7040.2003","article-title":"Intravetricular Brain Injection of Adeno-Associated Virus Type 1 (AAV1) in Neonatal Mice Results in Complementary Patterns of Neuronal Transduction to AAV2 and Total Long-Term Correction of Storage Lesions in the Brains of \u03b2-Glucuronidase-Deficient Mice","volume":"77","author":"Passini","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2025.10.022_bib56","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nature05901","article-title":"Transvascular delivery of small interfering RNA to the central nervous system","volume":"448","author":"Kumar","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.10.022_bib57","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nbt.1807","article-title":"Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes","volume":"29","author":"Alvarez-Erviti","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2025.10.022_bib58","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1007\/s11095-012-0667-y","article-title":"Targeted delivery of proteins into the central nervous system mediated by rabies virus glycoprotein-derived peptide","volume":"29","author":"Fu","year":"2012","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ymthe.2025.10.022_bib59","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ymthe.2016.12.010","article-title":"Rescue of Hearing by Gene Delivery to Inner-Ear Hair Cells Using Exosome-Associated AAV","volume":"25","author":"Gy\u00f6rgy","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.10.022_bib60","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/ncb2502","article-title":"Syndecan\u2013syntenin\u2013ALIX regulates the biogenesis of exosomes","volume":"14","author":"Baietti","year":"2012","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ymthe.2025.10.022_bib61","doi-asserted-by":"crossref","first-page":"E968","DOI":"10.1073\/pnas.1521230113","article-title":"Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes","volume":"113","author":"Kowal","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.10.022_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3402\/jev.v2i0.19861","article-title":"How pure are your vesicles?","volume":"2","author":"Webber","year":"2013","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.ymthe.2025.10.022_bib63","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.omtm.2020.07.012","article-title":"Simple and Fast SEC-Based Protocol to Isolate Human Plasma-Derived Extracellular Vesicles for Transcriptional Research","volume":"18","author":"Gaspar","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2025.10.022_bib64","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1016\/j.ymthe.2023.05.012","article-title":"Extracellular communication between brain cells through functional transfer of Cre mRNA mediated by Extracellular Vesicles","volume":"31","author":"Rufino-Ramos","year":"2023","journal-title":"Mol. Ther"},{"key":"10.1016\/j.ymthe.2025.10.022_bib65","doi-asserted-by":"crossref","DOI":"10.3390\/biom13020278","article-title":"Isolation of Extracellular Vesicles from Human Follicular Fluid: Size-Exclusion Chromatography versus Ultracentrifugation","volume":"13","author":"Soares","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.ymthe.2025.10.022_bib66","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1038\/s41598-017-02599-y","article-title":"Confounding factors of ultrafiltration and protein analysis in extracellular vesicle research","volume":"7","author":"Vergauwen","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2025.10.022_bib67","author":"Nobre"},{"key":"10.1016\/j.ymthe.2025.10.022_bib68","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/embor.2008.31","article-title":"Lentivector-mediated rescue from cerebellar ataxia in a mouse model of spinocerebellar ataxia","volume":"9","author":"Torashima","year":"2008","journal-title":"EMBO Rep."},{"key":"10.1016\/j.ymthe.2025.10.022_bib69","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-022-01329-4","article-title":"Cerebellar morphometric and spectroscopic biomarkers for Machado-Joseph Disease","volume":"10","author":"Miranda","year":"2022","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.ymthe.2025.10.022_bib70","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0958-1669(00)00080-X","article-title":"Production of viral vectors for gene therapy applications","volume":"11","author":"Wu","year":"2000","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.ymthe.2025.10.022_bib71","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.2174\/138161211798072472","article-title":"Gene Therapy for Parkinsons and Alzheimers Diseases: from the Bench to Clinical Trials","volume":"17","author":"Nobre","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ymthe.2025.10.022_bib72","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neuropharm.2016.02.013","article-title":"Viral vectors for therapy of neurologic diseases","volume":"120","author":"Choudhury","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ymthe.2025.10.022_bib73","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jconrel.2017.07.001","article-title":"Extracellular vesicles: Novel promising delivery systems for therapy of brain diseases","volume":"262","author":"Rufino-Ramos","year":"2017","journal-title":"J. Control Release"},{"key":"10.1016\/j.ymthe.2025.10.022_bib74","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.ymthe.2023.01.021","article-title":"Extracellular vesicles: The next generation in gene therapy delivery","volume":"31","author":"Cecchin","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.10.022_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2024.115346","article-title":"Exploring the potential of cell-derived vesicles for transient delivery of gene editing payloads","volume":"211","author":"Leandro","year":"2024","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ymthe.2025.10.022_bib76","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/s41580-022-00460-3","article-title":"Challenges and directions in studying cell\u2013cell communication by extracellular vesicles","volume":"23","author":"van Niel","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ymthe.2025.10.022_bib77","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/sj.leu.2404296","article-title":"Membrane-derived microvesicles: Important and underappreciated mediators of cell-to-cell communication","volume":"20","author":"Ratajczak","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.ymthe.2025.10.022_bib78","doi-asserted-by":"crossref","first-page":"e1001604","DOI":"10.1371\/journal.pbio.1001604","article-title":"Neurotransmitter-Triggered Transfer of Exosomes Mediates Oligodendrocyte-Neuron Communication","volume":"11","author":"Fr\u00fchbeis","year":"2013","journal-title":"PLoS Biol."},{"key":"10.1016\/j.ymthe.2025.10.022_bib79","doi-asserted-by":"crossref","first-page":"45329","DOI":"10.1038\/srep45329","article-title":"Exosome-associated AAV2 vector mediates robust gene delivery into the murine retina upon intravitreal injection","volume":"7","author":"Wassmer","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2025.10.022_bib80","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.omtm.2019.06.005","article-title":"Real-Time Monitoring of Exosome Enveloped-AAV Spreading by Endomicroscopy Approach: A New Tool for Gene Delivery in the Brain","volume":"14","author":"Orefice","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2025.10.022_bib81","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.omtm.2020.03.006","article-title":"AAV6 Vexosomes Mediate Robust Suicide Gene Delivery in a Murine Model of Hepatocellular Carcinoma","volume":"17","author":"Khan","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2025.10.022_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2020.197966","article-title":"Exosome-associated SUMOylation mutant AAV demonstrates improved ocular gene transfer efficiency in vivo","volume":"283","author":"Maurya","year":"2020","journal-title":"Virus Res."},{"key":"10.1016\/j.ymthe.2025.10.022_bib83","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/s12951-024-02511-7","article-title":"Brain-targeted drug delivery - nanovesicles directed to specific brain cells by brain-targeting ligands","volume":"22","author":"Moreira","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ymthe.2025.10.022_bib84","doi-asserted-by":"crossref","first-page":"789","DOI":"10.7150\/thno.18133","article-title":"Progress in Exosome Isolation Techniques","volume":"7","author":"Li","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.ymthe.2025.10.022_bib85","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1016\/j.xphs.2021.06.031","article-title":"Comprehensive Size Distribution and Composition Analysis of Adeno-Associated Virus Vector by Multiwavelength Sedimentation Velocity Analytical Ultracentrifugation","volume":"110","author":"Maruno","year":"2021","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ymthe.2025.10.022_bib86","doi-asserted-by":"crossref","first-page":"121366","DOI":"10.1016\/j.biomaterials.2022.121366","article-title":"Using genetically modified extracellular vesicles as a non-invasive strategy to evaluate brain-specific cargo","volume":"281","author":"Rufino-Ramos","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.ymthe.2025.10.022_bib87","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/mt.2010.279","article-title":"MicroRNA-regulated, systemically delivered rAAV9: a step closer to CNS-restricted transgene expression","volume":"19","author":"Xie","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.10.022_bib88","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2147\/IJN.S388916","article-title":"Surface Engineering of HEK293 Cell-Derived Extracellular Vesicles for Improved Pharmacokinetic Profile and Targeted Delivery of IL-12 for the Treatment of Hepatocellular Carcinoma","volume":"18","author":"Zhang","year":"2023","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ymthe.2025.10.022_bib89","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1021\/acsami.4c20294","article-title":"Efficient enzymatic glycan engineering of extracellular vesicles using nanomaterial-interfaced microfluidics","volume":"17","author":"Zhou","year":"2025","journal-title":"ACS Appl. Mater. Inter."},{"key":"10.1016\/j.ymthe.2025.10.022_bib90","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/s41417-021-00413-6","article-title":"Safety of Adeno-associated virus-based vector-mediated gene therapy\u2014impact of vector dose","volume":"29","author":"Maurya","year":"2022","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.ymthe.2025.10.022_bib91","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25021050","article-title":"Delivery of Adeno-Associated Virus Vectors to the Central Nervous System for Correction of Single Gene Disorders","volume":"25","author":"Daci","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2025.10.022_bib92","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/nprot.2006.207","article-title":"Production and characterization of adeno-associated viral vectors","volume":"1","author":"Grieger","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ymthe.2025.10.022_bib93","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1128\/JVI.78.9.4421-4432.2004","article-title":"Cross-Dressing the Virion: the Transcapsidation of Adeno-Associated Virus Serotypes Functionally Defines Subgroups","volume":"78","author":"Rabinowitz","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2025.10.022_bib94","first-page":"e66550","article-title":"Isolation of Adeno-Associated Viral Vectors Through a Single-Step and Semi-Automated Heparin Affinity Chromatography Protocol","volume":"393","author":"Lopes","year":"2024","journal-title":"J. Vis. Exp. JoVE"},{"key":"10.1016\/j.ymthe.2025.10.022_bib95","first-page":"3.22.1","article-title":"Isolation and Characterization of Exosomes from Cell Culture Supernatants","volume":"Chapter 3","author":"Th\u00e9ry","year":"2006","journal-title":"Curr. Protoc. Cell Biol."},{"key":"10.1016\/j.ymthe.2025.10.022_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2025.115413","article-title":"Differential impact of mutant Ataxin-3 in hindbrain regions: further evidence of white matter loss as a core pathological feature","volume":"393","author":"Henriques","year":"2025","journal-title":"Exp. Neurol."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625008433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625008433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T19:32:53Z","timestamp":1783020773000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001625008433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":96,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1525001625008433"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.10.022","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extracellular vesicles-associated AAVs for the treatment of Machado-Joseph disease","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.10.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}